Summary:
Clinical Trials of Texas, Inc. is conducting a research study to test the safety and effectiveness of an investigational medication or placebo (inactive substance) when added to an FDA approved medication for Bipolar I Disorder.
For qualified volunteers, the study may last up to 72 weeks and will include study-related testing and evaluations by a board-certified psychiatrist.
Qualified Participants Must:
• Currently be taking Depakote, Depakene or Lamictal
Qualified Participants May Receive:
Reimbursement up to $1675 for time and travel.